<DOC>
	<DOCNO>NCT00689416</DOCNO>
	<brief_summary>The primary aim study investigate effect 40 mg dose rosuvastatin carotid plaque inflammation measure MRI PET scanning , evaluate whether technique promise future proof principle study . A number patient receive placebo control .</brief_summary>
	<brief_title>Effects Crestor Inflammation Atherosclerotic Plaques</brief_title>
	<detailed_description />
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>Subjects noncalcified plaque least 2 mm least 6 mm length first MR scan uptake contrast agent dynamic MRI scan Signed write Informed Consent . Healthy men 18 70 year , woman 60 70 Use statin within six month randomization . Use lipid alter medication statin within last six month . Clinical evidence metabolic vascular disease require statin lipid lower pharmacological nonpharmacological treatment . Total cholesterol &gt; 8 , LDLC &gt; 6 TG &gt; 6 mmol/L enrolment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>image biomarkers</keyword>
	<keyword>MRI</keyword>
	<keyword>FDG-PET/CT scanning</keyword>
	<keyword>Crestor</keyword>
</DOC>